Moderna: Q3 Earnings Insights - Moderna (NASDAQ:MRNA)

Moderna MRNA reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Moderna missed estimated earnings by 23.1%, reporting an EPS of $2.53 versus an estimate of $3.29.

Revenue was down $1.60 billion from the same period last year.

Last quarter the company beat on EPS by $0.65 which was followed by a 4.12% increase in the share price the next day.

Here's a look at Moderna's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	4.59	5.21	9.90	9.09
EPS Actual	5.24	8.58	11.29	7.70
Revenue Estimate	4.07B	4.43B	6.79B	6.23B
Revenue Actual	4.75B	6.07B	7.21B	4.97B

To track all earnings releases for Moderna visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.